Sources: Lycia Therapeutics: upsized IPO pricing; Dubai Investments: DIP Holding intention to float

Lycia: base issue and optional shares

Million shares; priced October 22, 2026

08.8217.6417.64Base new shares2.65Additional option
Option exercise is unverified; October 26 settlement was expected after cutoff. [1]

Sources: [1] Lycia Therapeutics: upsized IPO pricing · October 22, 2026; expected October 26 settlement

Lycia prices its offering

Lycia Therapeutics announced October 22 an upsized offering of 17.64 million new shares at $18 each, approximately $317.5 million gross before expenses. It granted underwriters a 30-day option for another 2.646 million shares. The shares were expected to begin Nasdaq trading on October 23 under LYCA, with closing expected October 26, after this edition’s cutoff. This report verifies the pricing announcement, not a completed settlement or an actual first-day trading return. The optional shares are not treated as already sold. [1]

Dubai Investments plans a secondary sale

Dubai Investments announced October 19 an intention to offer 1,735,243,300 existing shares in DIP Holding, representing 20% of its issued capital. DIP Holding owns the company operating Dubai Investments Park. The proceeds would go to the selling parent, rather than constitute new equity raised by DIP Holding. Subscription was expected October 27–November 3, with admission around November 11, subject to approvals and market conditions. The announcement establishes a proposed offering timetable; it does not establish an offer price or completed listing. [2]

An IPO is not a single financing structure

Both transactions concern access to public equity markets, but the money takes a different route. Issuing new shares can finance the issuer and dilute existing owners. Selling existing shares transfers ownership and provides liquidity to the seller without itself adding cash to the operating company. An offering can also combine the two. That distinction should be visible before discussing growth funding or balance-sheet benefits. The size of an IPO headline is otherwise easily mistaken for the amount available to the business after the transaction.

Sources & methodology

Bracketed numbers refer to the sources below. Analysis is original editorial interpretation, not a personalized recommendation.

  1. Lycia Therapeutics: upsized IPO pricing · October 22, 2026; expected October 26 settlement
  2. Dubai Investments: DIP Holding intention to float · October 19, 2026; proposed October–November offering timetable